相关实验视频
Updated: May 6, 2026

04:36
Noninvasive Electrocardiography in the Perinatal Mouse
Published on: June 12, 2020
5.9K
孕期皮肤穿透冠状动脉干预:当代审查
Olayiwola Akeem Bolaji1, Yasemin Bahar2, Abdul Rasheed Bahar2
1From the Department of Medicine, Cardiology Division, Memorial Sloan Kettering Cancer Center, New York, NY.
Cardiology in review
|May 16, 2025
概括
在怀孕期间的穿皮冠状动脉干预 (PCI) 是可行的,并且对选定的患者是安全的. 本次审查强调PCI是首选的再血管化策略,强调通过修改技术和谨慎的药物选择来提高母亲和胎儿的安全性.
科学领域:
- 心脏病学 心脏病学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 干预心脏病学 干预心脏病学
背景情况:
- 心血管疾病是导致孕产妇死亡的主要原因.
- 急性冠状动脉综合征越来越多地在孕妇中被诊断出来.
- 怀孕涉及显著的生理心血管适应.
研究的目的:
- 审查当前对妊娠中穿皮冠状动脉干预 (PCI) 的理解.
- 检查病理生理学,指示,技术考虑和结果.
- 为管理需要冠状动脉干预的孕妇提供基于证据的建议.
主要方法:
- 对当代证据的综合文学综合.
- 专注于孕产妇和胎儿安全方面的考虑.
- 对程序修改和药物选择的分析.
主要成果:
- 在怀孕期间,PCI是适合适合的指示的首选重血管化策略.
- 具体的程序修改是必要的,以尽量减少风险.
- 多学科的方法对于最佳的管理至关重要.
结论:
- 穿皮冠状动脉干预可以在怀孕期间安全地进行.
- 仔细选择患者和量身定制的程序技术是必不可少的.
- 需要进一步的研究来优化管理策略.
相关概念视频
Intrauterine Drug Delivery Systems
170
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
170
Mitral Valve Prolapse III: Nursing Management
594
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
594
Coronary Artery Disease V: Interprofessional Care
452
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Acute Coronary Syndrome IV: Interprofessional Care
528
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Angina IV: Management
496
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
496
Peripheral Artery Disease III: Interprofessional Care
659
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659

